Pasar al contenido principal

EVENTOS MOLECULARES IMPLICADOS EN FISIPATOLOGIA TIROIDEA Y SUS TRATAMIENTOS

PID2021-125948OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario INSTITUTO DE SALUD CARLOS III DE MADRID (ISCIII)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Ultrasmall platinum nanoparticles for radiation-enhanced cancer therapy

  • Encinas-Giménez, Miguel
  • García-Peiro, José I.
  • Hueso, José L.
  • Caleiras, Eduardo
  • Notario, Laura
  • Hornos, Felipe
  • Martín-Duque, Pilar
  • Vieja, Antonio de la
  • Santamaría, Jesús
Despite decades of intense research, cancer remains a major global health challenge, with a clear need for new and more efficient therapies. Among emerging approaches, high atomic number (Z) nanomaterials capable of modulating the interaction between radiation and matter have attracted growing interest as radiotherapy enhancers. In this work, ultra-small Platinum-based nanoparticles with a metallic core diameter of 2–3 nm were synthesized from H2PtCl6 using polyvinylpyrrolidone as stabilizer. This nanomaterial exhibits low acute toxicity, catalase-like activity and enhances DNA damage under pre-clinical X-ray irradiation, increasing the antitumoral effect of X-ray alone. In vitro and in vivo studies, including intratumoral and intravenous administration, demonstrate improved tumor control and prolonged survival without detectable systemic toxicity under the tested conditions, establishing ultra-small Pt-nanoparticles as efficient materials for radiotherapy enhancement., The authors would like to acknowledge funding from the ERC Advanced Grant CADENCE project number 742684 and from Spanish Government Grant PID2023-148732NB-100. A.D.L.V acknowledges the Spanish Government grant PID2021-125948OB-I00 from MCIN/AEI/10.13039/501100011033/FEDER (UE) and P.M.D funding from Instituto de Salud Carlos lll, AESI 2024 PI24CIII/00046 and Ministerio de Ciencia, Innovación y Universidades. CNS2023-145442. The authors also thank CIBER-BBN, an initiative funded by the VI National R&D&i Plan 2008–2011 financed by the Instituto de Salud Carlos III (ISCIII) with the assistance of the European Regional Development Fund. M.E.G. and J.I.G.P. acknowledge the Aragon Regional Government for their predoctoral contracts. F.H. acknowledges the Generalitat Valenciana and the European Social Fund for an APOSTD fellowship (APOSTD/2021/196). The study was also supported by the Aragon Government via Research Group T57_23R. Severo Ochoa (CEX2023-001286-S) is acknowledged by MICIU/AEI/10.13039/501100011033., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2023-001286-S)., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Isolation and characterization of milk exosomes for use in advanced therapies

  • Medel-Martinez, Ana
  • Redrado-Osta, Ana
  • Crespo-Barreda, Alejandra
  • Sancho-Albero, Maria
  • Sánchez, Lourdes
  • Sebastián, Víctor
  • Pardo, María
  • de la Vieja, Antonio
  • Martín-Duque, Pilar
Exosomes are cell-derived extracellular vesicles (EVs) with diameters between 30 and 120 nm. In recent years, several studies have evaluated the therapeutic potential of exosomes derived from different fluids due to their low immunogenicity and high biocompatibility. However, producing exosomes on a large scale is still challenging. One of the fluids from which they could be isolated in large quantities is milk. Moreover, regeneration is a well-known property of milk. The present work seeks to optimize a method for isolating exosomes from bovine and human milk, comparing different storage conditions and different extraction protocols. We found differences in the yield extraction associated with pre-storage milk conditions and observed some differences according to the processing agent. When we removed milk fat globules and added rennet before freezing, we obtained a cleaner final fraction. In summary, we attempted to optimize a rennet-based new milk–exosome isolation method and concluded that pre-treatment, followed by freezing of samples, yielded the best exosome population.